🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
42.5124.617.7629.6647.0458.51
Short-Term Investments
264.1340.62339.95252.61280.78312.54
Trading Asset Securities
25.03-453.02-
Cash & Short-Term Investments
331.64365.22361.71287.27330.84371.05
Cash Growth
-13.16%0.97%25.91%-13.17%-10.84%-6.09%
Accounts Receivable
4.729.3420.6611.354.515.78
Other Receivables
0.030.020.01-0.060.13
Receivables
4.759.3720.6611.354.575.91
Inventory
25.0127.3430.0925.0223.3321.24
Prepaid Expenses
1.322.041.282.071.022.03
Other Current Assets
0.196.034.340.180.120.31
Total Current Assets
362.9410418.09325.89359.88400.54
Property, Plant & Equipment
81.3775.2182.9282.7179.8188.23
Long-Term Investments
11175.8125.6828.0628.7434.47
Goodwill
-31.1831.1831.1831.1831.18
Other Intangible Assets
55.2428.7735.1542.550.5458.62
Other Long-Term Assets
1.851.751.872.33.722.72
Total Assets
612.35622.7694.87512.65553.86615.75

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.751.322.741.951.061.15
Current Portion of Leases
4.821.315.154.43.884.42
Current Unearned Revenue
0.990.460.512.052.675.45
Other Current Liabilities
13.3415.0416.7516.0219.7515.11
Total Current Liabilities
21.918.1325.1424.4227.3626.13
Long-Term Leases
7.363.445.729.996.4310.31
Other Long-Term Liabilities
0.320.320.290.290.290.28
Total Liabilities
29.5721.8831.1634.734.0836.72

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
633.33633.33633.33532.56532.21532.21
Additional Paid-In Capital
-142.17141.528.0295.7494.92
Retained Earnings
-294.66-253.08-199.32-148.74-192.06-138.57
Comprehensive Income & Other
176.76-0.99-6.88-11.25-11.32-5.59
Total Common Equity
515.43521.42568.65380.58424.58482.98
Minority Interest
67.3679.495.0797.3795.296.06
Shareholders' Equity
582.78600.82663.72477.95519.78579.03
Total Liabilities & Equity
612.35622.7694.87512.65553.86615.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
12.184.7510.8714.3910.3114.73
Net Cash (Debt)
319.46360.47350.84272.88320.53356.32
Net Cash Growth
-15.02%2.75%28.57%-14.87%-10.04%-8.84%
Net Cash Per Share
5.055.696.085.136.026.70
Filing Date Shares Outstanding
61.6763.3363.3353.2653.2253.22
Total Common Shares Outstanding
61.6763.3363.3353.2653.2253.22
Working Capital
341391.87392.94301.47332.52374.41
Book Value Per Share
8.368.238.987.157.989.07
Tangible Book Value
460.18461.48502.33306.9342.87393.18
Tangible Book Value Per Share
7.467.297.935.766.447.39
Land
-52.9452.9452.9452.9452.94
Buildings
-8.148.148.148.148.14
Machinery
-14.9915.5725.1548.4747.34
Leasehold Improvements
----0.820.82